Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeanclos, E.
Right arrow Articles by Aviv, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeanclos, E.
Right arrow Articles by Aviv, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 47, Issue 3 482-486, Copyright © 1998 by American Diabetes Association


ARTICLES

Shortened telomere length in white blood cells of patients with IDDM

E Jeanclos, A Krolewski, J Skurnick, M Kimura, H Aviv, JH Warram and A Aviv
Hypertension Research Center, Department of Preventive Medicine and Community Health, University of Medicine and Dentistry of New Jersey, Newark 07103-2714, USA.

IDDM is a polygenic and autoimmune disorder in which subsets of white blood cells (WBCs) are engaged in the destruction of beta-cells of the pancreas. The mechanisms that account for the abnormal behavior of these cells in IDDM are not fully understood. By measuring the mean length of telomeres of WBCs from patients with IDDM, we tested the concept that telomeres might play a role in IDDM. We examined the lengths of the terminal restriction fragments (TRFs) of DNA of WBCs from 234 white men comprising 54 patients with IDDM, 74 patients with NIDDM, and 106 control subjects. When adjusted for age, the TRF length from WBCs of patients with IDDM was significantly shorter than that of nondiabetic control subjects (mean +/- SE: 8.6 +/- 0.1 vs. 9.2 +/- 0.1, P = 0.002). No significant difference was observed between the TRF length from WBCs of patients with NIDDM versus nondiabetic subjects. Neither the duration nor the complications of IDDM (i.e., nephropathy and hypertension) had an effect on the TRF length of WBCs from patients with IDDM. The shortened TRF length of WBCs of patients with IDDM likely reflects a marked reduction in the TRF length of subsets of WBCs that play a role in the pathogenesis of IDDM.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
N. Tentolouris, R. Nzietchueng, V. Cattan, G. Poitevin, P. Lacolley, A. Papazafiropoulou, D. Perrea, N. Katsilambros, and A. Benetos
White Blood Cells Telomere Length Is Shorter in Males With Type 2 Diabetes and Microalbuminuria
Diabetes Care, November 1, 2007; 30(11): 2909 - 2915.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. C. Capell, F. S. Collins, and E. G. Nabel
Mechanisms of Cardiovascular Disease in Accelerated Aging Syndromes
Circ. Res., July 6, 2007; 101(1): 13 - 26.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. P. Gardner, M. Kimura, W. Chai, J. F. Durrani, L. Tchakmakjian, X. Cao, X. Lu, G. Li, A. P. Peppas, J. Skurnick, et al.
Telomere Dynamics in Macaques and Humans
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2007; 62(4): 367 - 374.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Minamino and I. Komuro
Vascular Cell Senescence: Contribution to Atherosclerosis
Circ. Res., January 5, 2007; 100(1): 15 - 26.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. L. Fitzpatrick, R. A. Kronmal, J. P. Gardner, B. M. Psaty, N. S. Jenny, R. P. Tracy, J. Walston, M. Kimura, and A. Aviv
Leukocyte Telomere Length and Cardiovascular Disease in the Cardiovascular Health Study
Am. J. Epidemiol., January 1, 2007; 165(1): 14 - 21.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. J. Fuster and V. Andres
Telomere Biology and Cardiovascular Disease
Circ. Res., November 24, 2006; 99(11): 1167 - 1180.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. J. Sampson, M. S. Winterbone, J. C. Hughes, N. Dozio, and D. A. Hughes
Monocyte Telomere Shortening and Oxidative DNA Damage in Type 2 Diabetes
Diabetes Care, February 1, 2006; 29(2): 283 - 289.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. S. Najjar, A. Scuteri, and E. G. Lakatta
Arterial Aging: Is It an Immutable Cardiovascular Risk Factor?
Hypertension, September 1, 2005; 46(3): 454 - 462.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. P. Gardner, S. Li, S. R. Srinivasan, W. Chen, M. Kimura, X. Lu, G. S. Berenson, and A. Aviv
Rise in Insulin Resistance Is Associated With Escalated Telomere Attrition
Circulation, May 3, 2005; 111(17): 2171 - 2177.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. L. Serrano and V. Andres
Telomeres and Cardiovascular Disease: Does Size Matter?
Circ. Res., March 19, 2004; 94(5): 575 - 584.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Brouilette, R. K. Singh, J. R. Thompson, A. H. Goodall, and N. J. Samani
White Cell Telomere Length and Risk of Premature Myocardial Infarction
Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 842 - 846.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Aviv
Hypothesis : Pulse Pressure and Human Longevity
Hypertension, April 1, 2001; 37(4): 1060 - 1066.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Jeanclos, N. J. Schork, K. O. Kyvik, M. Kimura, J. H. Skurnick, and A. Aviv
Telomere Length Inversely Correlates With Pulse Pressure and Is Highly Familial
Hypertension, August 1, 2000; 36(2): 195 - 200.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Engelhardt, K. Mackenzie, P. Drullinsky, R. T. Silver, and M. A. S. Moore
Telomerase Activity and Telomere Length in Acute and Chronic Leukemia, Pre- and Post-ex Vivo Culture
Cancer Res., February 1, 2000; 60(3): 610 - 617.
[Abstract] [Full Text]


Home page
JEMHome page
N. Rufer, T. H. Brummendorf, S. Kolvraa, C. Bischoff, K. Christensen, L. Wadsworth, M. Schulzer, and P. M. Lansdorp
Telomere Fluorescence Measurements in Granulocytes and T Lymphocyte Subsets Point to a High Turnover of Hematopoietic Stem Cells and Memory T Cells in Early Childhood
J. Exp. Med., July 19, 1999; 190(2): 157 - 168.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1998 by the American Diabetes Association.